Page last updated: 2024-08-18

isomethyleugenol and Histiocytic Disorders, Malignant

isomethyleugenol has been researched along with Histiocytic Disorders, Malignant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carrasco, DR; Cavenee, WK; Depinho, RA; Di Vizio, D; Divicio, D; Enos, M; Fenton, T; Fletcher, C; Furnari, FB; Hornick, JL; Nogueira, C; Pinkus, GS; Protopopova, M; Stommel, J; Sukhdeo, K; You, MJ	1

Other Studies

1 other study(ies) available for isomethyleugenol and Histiocytic Disorders, Malignant

Article	Year
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. Cancer cell, 2006, Volume: 9, Issue:5 Topics: Animals; Cyclin-Dependent Kinase Inhibitor p16; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Histiocytic Disorders, Malignant; Homeostasis; Humans; Immunophenotyping; Lymphocytes; Methylation; Mice; Mutation; Myeloid Cells; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Sarcoma; Tumor Suppressor Protein p14ARF	2006

Article

Year

The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans.

Cancer cell, 2006, Volume: 9, Issue:5

Topics: Animals; Cyclin-Dependent Kinase Inhibitor p16; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Histiocytic Disorders, Malignant; Homeostasis; Humans; Immunophenotyping; Lymphocytes; Methylation; Mice; Mutation; Myeloid Cells; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Sarcoma; Tumor Suppressor Protein p14ARF

2006